Itpc Latca Opposition, Nirmatrelvir/Ritonavir, (Hn/P/2021/002695 Wo2021250648)
No Annotations
Alert me when there are new annotations for this document
4 similar patent oppositions
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (VN1-2021-07603 / WO/2021/250648)
Countries: Viet Nam Date: 2023
-
Fundación Grupo Efecto Positivo opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (AR123111A1)
Countries: Argentina Date: 2022
-
TNP+ opposition, Nirmatrelvir/Ritonavir [Paxlovid], (TH2101007038, WO/2021/250648, PCT/IB2021/057281)
Countries: Thailand Date: 2026
-
Grupo de Investigación Plebio-Universidad Nacional de Colombia-UNAL. JDR, FHT, Oscar Lizarazo. UAEM-UNAL-Colombia; Centro de Pensamiento, Medicamentos-UNAL and Others opposition, Nirmatrelvir / Ritonavir (Paxlovid), (PCT/IB2021/057281 WO/2021/250648 )
Countries: Colombia Date: 2022